Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging roles of DYRK2 in cancer
Vasudha Tandon, Laureano de la Vega, Sourav Banerjee
Journal of Biological Chemistry (2020) Vol. 296, pp. 100233-100233
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The regulations of telomerase reverse transcriptase (TERT) in cancer
Mingdi Liu, Yuning Zhang, Yong‐Ping Jian, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 28
Origins and evolution of extreme life span in Pacific Ocean rockfishes
Sree Rohit Raj Kolora, Gregory L. Owens, Juan Manuel Vázquez, et al.
Science (2021) Vol. 374, Iss. 6569, pp. 842-847
Open Access | Times Cited: 104
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
Mattias F. Lindberg, Laurent Meijer
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6047-6047
Open Access | Times Cited: 81
Synthesis of N-(4-chlorophenyl) substituted pyrano[2,3-c]pyrazoles enabling PKBβ/AKT2 inhibitory and in vitro anti-glioma activity
Ruturajsinh M. Vala, Vasudha Tandon, Lynden Guy Nicely, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 2548-2560
Open Access | Times Cited: 26
FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2
Rafael Jiménez‐Izquierdo, Rosario Morrugares, Lucía Suanes-Cobos, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 16
Targeting purine metabolism-related enzymes for therapeutic intervention: A review from molecular mechanism to therapeutic breakthrough
Di Wu, Shengqiang Yang, Chenyang Yuan, et al.
International Journal of Biological Macromolecules (2024), pp. 136828-136828
Closed Access | Times Cited: 6
Design, Synthesis, and Molecular Docking Studies of Curcumin Hybrid Conjugates as Potential Therapeutics for Breast Cancer
Siva S. Panda, Queen L. Tran, Pragya Rajpurohit, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 451-451
Open Access | Times Cited: 18
Good Cop, Bad Cop: The Different Roles of SRPKs
Eleni Nikolakaki, Ioanna Sigala, Thomas Giannakouŕos
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 18
A novel CDC25A/DYRK2 regulatory switch modulates cell cycle and survival
Maribel Lara‐Chica, Alejandro Correa-Sáez, Rafael Jiménez‐Izquierdo, et al.
Cell Death and Differentiation (2021) Vol. 29, Iss. 1, pp. 105-117
Open Access | Times Cited: 21
Syrbactin-class dual constitutive- and immuno-proteasome inhibitor TIR-199 impedes myeloma-mediated bone degenerationin vivo
Vasudha Tandon, Ruturajsinh M. Vala, Albert Chen, et al.
Bioscience Reports (2022) Vol. 42, Iss. 2
Open Access | Times Cited: 16
Targeting Protein Degradation Pathways in Tumors: Focusing on their Role in Hematological Malignancies
Anna Wolska, Piotr Smolewski
Cancers (2022) Vol. 14, Iss. 15, pp. 3778-3778
Open Access | Times Cited: 15
Discovery of Potent DYRK2 Inhibitors with High Selectivity, Great Solubility, and Excellent Safety Properties for the Treatment of Prostate Cancer
Kai Yuan, Hongtao Shen, Mingming Zheng, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 6, pp. 4215-4230
Closed Access | Times Cited: 9
Dual inhibition of HSF1 and DYRK2 impedes cancer progression
Vasudha Tandon, Rita Moreno, Kira Allmeroth, et al.
Bioscience Reports (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer
Kai Yuan, Zhaoxing Li, Wenbin Kuang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Motor domain phosphorylation increases nucleotide exchange and turns MYO6 into a faster and stronger motor
Janeska J. de Jonge, Andreas Graw, Vasileios Kargas, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
DYRK2 promotes chemosensitivity via p53‐mediated apoptosis after DNA damage in colorectal cancer
Yasuhiro Takano, Satomi Yogosawa, Yuta Imaizumi, et al.
Cancer Science (2023) Vol. 114, Iss. 12, pp. 4558-4570
Open Access | Times Cited: 6
A Bioinformatics Evaluation of the Role of Dual-Specificity Tyrosine-Regulated Kinases in Colorectal Cancer
Amina Jamal Laham, Raafat El‐Awady, Jean‐Jacques Lebrun, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2034-2034
Open Access | Times Cited: 10
Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis
Ameen A. Salahudeen, José A. Seoane, Kanako Yuki, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113355-113355
Open Access | Times Cited: 5
Association between Alcohol Consumption and DNA Methylation in Blood: A Systematic Review of Observational Studies
Dzevka Dragic, Sue-Ling Chang, Kaoutar Ennour-Idrissi, et al.
Epigenomics (2022) Vol. 14, Iss. 12, pp. 793-810
Open Access | Times Cited: 8
Sex differences in the intergenerational link between maternal and neonatal whole blood DNA methylation: a genome-wide analysis in 2 birth cohorts
Jie Hu, Xin Xu, Jun Li, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 782-819
Closed Access | Times Cited: 4
Functions of SRPK, CLK and DYRK kinases in stem cells, development, and human developmental disorders
Elizabeth Hogg, Greg M. Findlay
FEBS Letters (2023) Vol. 597, Iss. 19, pp. 2375-2415
Open Access | Times Cited: 4
Functional Roles of DYRK2 as a Tumor Regulator
Yuta Mochimaru, Kiyotsugu Yoshida
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 10, pp. 8539-8551
Open Access | Times Cited: 4
A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma
Tianwei Wang, Piji Chen, Tingting Li, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 17, pp. 2378-2399
Closed Access | Times Cited: 1
Dual specificity kinase DYRK3 regulates cell migration by influencing the stability of protrusions
Martina Ramella, Lucrezia Maria Ribolla, Sara Surini, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109440-109440
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top